Natus Medical Company Profile (NASDAQ:BABY)

About Natus Medical

Natus Medical logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: BABY
  • CUSIP: 63905010
Key Metrics:
  • Previous Close: $40.10
  • 50 Day Moving Average: $41.16
  • 200 Day Moving Average: $37.40
  • 52-Week Range: $29.54 - $51.05
  • Trailing P/E Ratio: 32.17
  • Foreward P/E Ratio: 21.81
  • P/E Growth: 1.11
  • Market Cap: $1.27B
  • Outstanding Shares: 32,388,000
  • Beta: 0.78
  • Net Margins: 10.89%
  • Return on Equity: 13.53%
  • Return on Assets: 11.03%
  • Current Ratio: 2.98%
  • Quick Ratio: 2.61%
Additional Links:
Companies Related to Natus Medical:

Analyst Ratings

Consensus Ratings for Natus Medical (NASDAQ:BABY) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $46.67 (18.90% upside)

Analysts' Ratings History for Natus Medical (NASDAQ:BABY)
DateFirmActionRatingPrice TargetDetails
10/4/2016Benchmark Co.Initiated CoverageBuy$55.00View Rating Details
9/13/2016Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$46.00View Rating Details
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 10/27/2014 forward)


Earnings History for Natus Medical (NASDAQ:BABY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.39$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Natus Medical (NASDAQ:BABY)
Current Year EPS Consensus Estimate: $1.64 EPS
Next Year EPS Consensus Estimate: $1.8 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.29$0.32$0.31
Q2 20161$0.35$0.35$0.35
Q3 20162$0.37$0.42$0.40
Q4 20162$0.52$0.55$0.54
Q1 20171$0.43$0.43$0.43
Q2 20171$0.44$0.44$0.44
Q3 20171$0.41$0.41$0.41
Q4 20171$0.52$0.52$0.52
(Data provided by Zacks Investment Research)


Dividend History for Natus Medical (NASDAQ:BABY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Natus Medical (NASDAQ:BABY)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 88.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.40View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.18View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.00View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.00View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.50View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.00View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.76View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.44View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.00View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.54View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.00View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.50View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Natus Medical (NASDAQ:BABY)
News IconInside Transaction: Jonathan Kennedy Sold 30276 Shares of Natus Medical Inc (NASDAQ:BABY) - Thorold News (NASDAQ:BABY) - October 27 at 8:11 AM
News Icon3250 Shares of Stock are sold by Natus Medical Inc. (BABY) Director Robert A. Gunst - DailyQuint (NASDAQ:BABY) - October 27 at 8:11 AM
News IconFY2016 EPS Estimates for Natus Medical Inc. Upgraded by Analyst (BABY) - DailyQuint (NASDAQ:BABY) - October 27 at 8:11 AM logoShares of BABY Up 18.7% Since Uptrend Call on Shares (NASDAQ:BABY) - October 26 at 12:40 PM
News IconNatus Medical Incorporated (NASDAQ:BABY) Updated Broker Price Targets (NASDAQ:BABY) - October 26 at 12:40 PM
News IconWilliam Blair Analysts Increase Earnings Estimates for Natus Medical Inc. (BABY) - DailyQuint (NASDAQ:BABY) - October 25 at 8:51 PM
News IconBurgeoning Growth Expected For Natus Medical Inc. (NASDAQ:BABY) - CSZ News (NASDAQ:BABY) - October 25 at 3:43 PM
News IconSell-side Taking Aim at Earnings Projections for Natus Medical Inc. (NASDAQ:BABY) - CSZ News (NASDAQ:BABY) - October 22 at 5:01 AM logoNatus Medical Incorporated (NASDAQ:BABY) Files An 8-K (NASDAQ:BABY) - October 20 at 9:40 PM
News IconNatus Medical Inc. (BABY) Updates Q4 Earnings Guidance (NASDAQ:BABY) - October 20 at 9:40 PM
News IconNatus Medical Inc. (BABY) to Release Earnings on Wednesday (NASDAQ:BABY) - October 20 at 9:40 PM
News IconNatus Medical Inc. (BABY) Trading 9.2% Higher Following Better-Than-Expected Earnings (NASDAQ:BABY) - October 20 at 9:40 PM logoCERU Gains Big On Nanoparticle Deal, LLY Gets FDA Nod, BABY Makes Big Strides - Nasdaq (NASDAQ:BABY) - October 20 at 4:09 PM logoNatus Medical Inc.: This BABY Keeps Chugging Along - Motley Fool (NASDAQ:BABY) - October 20 at 4:09 PM logoNatus Medical Inc.: This BABY Keeps Chugging Along (NASDAQ:BABY) - October 20 at 1:45 PM logoNatus Medical : beats 3Q profit forecasts (NASDAQ:BABY) - October 20 at 9:36 AM logoWhy Halliburton, GNC Holdings, and Natus Medical Jumped Today (NASDAQ:BABY) - October 19 at 5:22 PM logoETF’s with exposure to Natus Medical, Inc. : October 19, 2016 (NASDAQ:BABY) - October 19 at 4:32 PM logoNatus Medical (BABY) Stock Surges on Q3 Results, Guidance (NASDAQ:BABY) - October 19 at 4:32 PM logoNatus Medical Announces Third Quarter 2016 Financial Results (NASDAQ:BABY) - October 19 at 8:39 AM logoNatus Medical beats 3Q profit forecasts (NASDAQ:BABY) - October 19 at 8:39 AM logoQ3 2016 Natus Medical Inc Earnings Release - Before Market Open (NASDAQ:BABY) - October 19 at 8:39 AM logoNatus Medical beats by $0.05, beats on revenue (NASDAQ:BABY) - October 19 at 6:28 AM logoNatus Medical Q3 revenues off 4%; earnings up 21% in Q3; updates guidance (NASDAQ:BABY) - October 19 at 6:28 AM logoShares of BABY Up 18.9% Since Uptrend Call on Shares (NASDAQ:BABY) - October 18 at 3:44 PM logoNatus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : October 18, 2016 (NASDAQ:BABY) - October 18 at 3:44 PM logoMedical Device Q3 Earnings Queued Up for Oct 18: STJ & BABY (NASDAQ:BABY) - October 18 at 8:34 AM logoNatus Medical (BABY) Q3 Earnings: What's in the Cards? (NASDAQ:BABY) - October 17 at 8:35 AM
News IconOwnership Action Alert: Natus Medical Inc (NASDAQ:BABY) Quarterly Sentiment Report - Post News (NASDAQ:BABY) - October 12 at 3:56 PM logoNatus Medical Shares Up 24.5% Since SmarTrend's Buy Recommendation (BABY) (NASDAQ:BABY) - October 12 at 8:05 AM
News IconStock Forging Ahead with Pace: Natus Medical Inc. (NASDAQ:BABY) - CSZ News (NASDAQ:BABY) - October 11 at 3:47 PM
News IconShort Interest Alert: Is Buying Natus Medical Incorporated (NASDAQ:BABY), Having Lower Short Interest a Winning ... - Post News (NASDAQ:BABY) - October 10 at 3:40 PM logoNatus Medical Inc 36.2% Potential Upside Now Implied by The Benchmark Company - DirectorsTalk Interviews (NASDAQ:BABY) - October 5 at 8:34 AM logoNatus Medical to Hold 2016 Third Quarter Financial Results Conference Call on October 19th (NASDAQ:BABY) - October 5 at 8:34 AM logoETF’s with exposure to Natus Medical, Inc. : October 4, 2016 (NASDAQ:BABY) - October 4 at 3:42 PM logoNatus Medical CEO Acquires Shares in Company (NASDAQ:BABY) - September 30 at 8:57 AM logoNatus Medical Incorporated (NASDAQ:BABY) Trading Up – Insiders Buying, Short Interest Falling (NASDAQ:BABY) - September 29 at 8:46 AM logoNatus Medical, Inc. – Value Analysis (NASDAQ:BABY) : September 28, 2016 (NASDAQ:BABY) - September 28 at 3:47 PM
News IconAnalysts Valuations For Two Stocks: Tokai Pharmaceuticals Inc (NASDAQ:TKAI), Natus Medical Inc (NASDAQ:BABY) - The Voice Registrar (NASDAQ:BABY) - September 27 at 3:42 PM logoNatus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : September 27, 2016 (NASDAQ:BABY) - September 27 at 3:42 PM logoGW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH ... - Insider Monkey (blog) (NASDAQ:BABY) - September 27 at 8:19 AM
News IconEye Catching Active Stocks: Columbia Pipeline Partners (NYSE:CPPL), Natus Medical (NASDAQ:BABY), RetailMeNot ... - Street Wise Report (press release) (blog) (NASDAQ:BABY) - September 27 at 8:19 AM logoNatus Medical Inc. (BABY) Fell To A 3-Week Low After Q3 Outlook Lowered - RTT News (NASDAQ:BABY) - September 27 at 8:19 AM logoMid-Afternoon Market Update: Dow Falls 150 Points; Himax Technologies Shares Slide After Nomura Downgrade - Nasdaq (NASDAQ:BABY) - September 26 at 3:50 PM logoNatus Medical Inc. (BABY) Is Sinking After Acquisition & Reduced Q3 Outlook - Nasdaq (NASDAQ:BABY) - September 26 at 3:50 PM logoNatus Medical (BABY) Stock Drops on Downbeat Q3 Forecast (NASDAQ:BABY) - September 26 at 3:50 PM logoMid-Afternoon Market Update: Dow Falls 150 Points; Himax Technologies Shares Slide After Nomura Downgrade (NASDAQ:BABY) - September 26 at 3:39 PM logoWhy Natus Medical Inc Slipped Today (NASDAQ:BABY) - September 26 at 1:58 PM logoNATUS MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitiv (NASDAQ:BABY) - September 26 at 8:28 AM logoNatus Enters into Agreement to Acquire GN Otometrics; Provides Q3 Revenue Update (NASDAQ:BABY) - September 26 at 8:28 AM


Natus Medical (NASDAQ:BABY) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff